Back
Akebia Therapeutics Vs. Bioventus Industry Stock Comparison
Buy
63
AKBA
Akebia Therapeutics
Last Price:
1.87
Seasonality Move:
46.76%
Buy
67
BVS
Bioventus
Last Price:
11.76
Seasonality Move:
-1.84%
Buy
63
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.88. The Score for AKBA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $11.71. The Score for BVS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BVS Stock Price Chart
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 61.05 | Buy |
| Chaikin Money Flow: | 1174085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.62 - 1.92) | Buy |
| Bollinger Bands (100): | (1.22 - 1.68) | Buy |
BVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | 109846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.35 - 13.25) | Sell |
| Bollinger Bands (100): | (7.76 - 12.34) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 1.55 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.84 | Buy |
| 20-day EMA: | 1.79 | Buy |
| 50-day EMA: | 1.63 | Buy |
| 200-day EMA: | 1.41 | Buy |
BVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.38 | Buy |
| 20-day SMA: | 12.1 | Sell |
| 50-day SMA: | 12.02 | Sell |
| 200-day SMA: | 7.68 | Buy |
| 8-day EMA: | 11.57 | Buy |
| 20-day EMA: | 11.84 | Sell |
| 50-day EMA: | 11.54 | Buy |
| 200-day EMA: | 8.52 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.25 per share.
Akebia Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bioventus Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||